Autologuous umbilical cord blood mononuclear cells (Guangdong Women and Children Hospital)

N/A

Report date: 2023/01/07 18:44:00

Base Information

Drug NameAutologuous umbilical cord blood mononuclear cells (Guangdong Women and Children Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Umbilical cord blood-derivedCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsObstetric Labor, Premature
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangdong Women And Children Hospital
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Women And Children Hospital
Inactive CompaniesN/A
Active IndicationsObstetric Labor, Premature
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A